Literature DB >> 6207176

Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction.

M M Rweyemamu.   

Abstract

The neutralization reaction is the most appropriate in vitro reference test system for assessing intratypic antigenic variation as it involves the antigenic determinants responsible for virus strain specificity and evoking protective antibody. Antigenic relationships determined in different neutralization test systems were independent of the system used and were assumed to truly reflect antigenic variation. The two-dimensional microneutralization test was found to be appropriate for foot and mouth disease (FMD) virus strain differentiation. To minimize test to test variation, comparisons are performed as matched pairs. The pooled variance of the test system is used to assess the significance of the relationships obtained. Antisera from convalescent animals were less specific than those from vaccinates. Serum quality seemed less critical for the virus neutralization than the complement fixation reaction. A system for FMD virus strain differentiation based on the use of the virus neutralization reaction taking into account the statistical and biological significance of observed r values is recommended.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207176     DOI: 10.1016/s0092-1157(84)80013-x

Source DB:  PubMed          Journal:  J Biol Stand        ISSN: 0092-1157


  13 in total

Review 1.  Development of foot-and-mouth disease virus strain characterisation--a review.

Authors:  R P Kitching; N J Knowles; A R Samuel; A I Donaldson
Journal:  Trop Anim Health Prod       Date:  1989-08       Impact factor: 1.559

2.  Comparison of test methodologies for foot-and-mouth disease virus serotype A vaccine matching.

Authors:  Tesfaalem Tekleghiorghis; Klaas Weerdmeester; Froukje van Hemert-Kluitenberg; Rob J M Moormann; Aldo Dekker
Journal:  Clin Vaccine Immunol       Date:  2014-03-12

3.  Vaccine matching and antigenic variability of foot-and-mouth disease virus serotypes O and A from 2018 Ethiopian isolates.

Authors:  Yeneneh Tesfaye; Fazlurrahman Khan; Esayas Gelaye
Journal:  Int Microbiol       Date:  2021-07-05       Impact factor: 2.479

4.  Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus.

Authors:  Richard Reeve; Belinda Blignaut; Jan J Esterhuysen; Pamela Opperman; Louise Matthews; Elizabeth E Fry; Tjaart A P de Beer; Jacques Theron; Elizabeth Rieder; Wilna Vosloo; Hester G O'Neill; Daniel T Haydon; Francois F Maree
Journal:  PLoS Comput Biol       Date:  2010-12-09       Impact factor: 4.475

5.  A Brief Review on Diagnosis of Foot-and-Mouth Disease of Livestock: Conventional to Molecular Tools.

Authors:  Neeta Longjam; Rajib Deb; A K Sarmah; Tilling Tayo; V B Awachat; V K Saxena
Journal:  Vet Med Int       Date:  2011-07-06

6.  The conserved N-terminus of human rhinovirus capsid protein VP4 contains membrane pore-forming activity and is a target for neutralizing antibodies.

Authors:  Anusha Panjwani; Amin S Asfor; Tobias J Tuthill
Journal:  J Gen Virol       Date:  2016-10-11       Impact factor: 3.891

7.  Foot-and-mouth disease virus serotype A in Egypt.

Authors:  Nick J Knowles; Jemma Wadsworth; Scott M Reid; Katherine G Swabey; Alaa A El-Kholy; Adel Omar Abd El-Rahman; Hatem M Soliman; Katja Ebert; Nigel P Ferris; Geoffrey H Hutchings; Robert J Statham; Donald P King; David J Paton
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

8.  Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection.

Authors:  Ming Yang; Wanhong Xu; Melissa Goolia; Zhidong Zhang
Journal:  Virol J       Date:  2014-08-01       Impact factor: 4.099

9.  Emergence of antigenic variants within serotype A FMDV in the Middle East with antigenically critical amino acid substitutions.

Authors:  Mana Mahapatra; Bob Statham; Yanmin Li; Jef Hammond; David Paton; Satya Parida
Journal:  Vaccine       Date:  2016-03-24       Impact factor: 3.641

10.  Evaluation of a polyvalent foot-and-mouth disease virus vaccine containing A Saudi-95 against field challenge on large-scale dairy farms in Saudi Arabia with the emerging A/ASIA/G-VII viral lineage.

Authors:  Nicholas A Lyons; Anna B Ludi; Ginette Wilsden; Pip Hamblin; Ibrahim Ahmed Qasim; Simon Gubbins; Donald P King
Journal:  Vaccine       Date:  2017-11-03       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.